{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:31:43Z","timestamp":1765827103921},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jval.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T10:48:43Z","timestamp":1373971723000},"page":"909-921","source":"Crossref","is-referenced-by-count":13,"title":["Genetic Screening for the Predisposition to Venous Thromboembolism: A Cost-Utility Analysis of Clinical Practice in the Italian Health Care System"],"prefix":"10.1016","volume":"16","author":[{"given":"Amelia","family":"Compagni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Melegaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2013.05.003_bib1","series-title":"Genomic Medicine","author":"House of Lords Science and Technology Committee","year":"2009"},{"key":"10.1016\/j.jval.2013.05.003_bib2","series-title":"Genetics and Mainstream Medicine","author":"Burton","year":"2011"},{"key":"10.1016\/j.jval.2013.05.003_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0272989X03254456","article-title":"The use of gene test to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?","volume":"23","author":"Col","year":"2003","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.05.003_bib4","series-title":"Pharmacogenetics and Pharmacogenomics: State-of-the-Art and Potential Socio-Economic Impacts in the EU","author":"Zika","year":"2006"},{"key":"10.1016\/j.jval.2013.05.003_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1525-1578(10)60002-5","article-title":"Food and drug administration of in vitro diagnostic devices","volume":"7","author":"Mansfield","year":"2005","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jval.2013.05.003_bib6","first-page":"197","article-title":"Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests","volume":"12","author":"Ramsey","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2013.05.003_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.genom.9.081307.164319","article-title":"The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues","volume":"9","author":"Hogarth","year":"2008","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.jval.2013.05.003_bib8","unstructured":"Haddow JE, Palomaki GE. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury MJ, Little J, Burke W, eds., Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. New York: Oxford, 2004:217\u201333."},{"key":"10.1016\/j.jval.2013.05.003_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GIM.0b013e318184137c","article-title":"The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group","volume":"11","author":"Teutsch","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.jval.2013.05.003_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.GIM.0000182467.79495.e2","article-title":"Economic analyses of human genetics services: a systematic review","volume":"7","author":"Carlson","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.jval.2013.05.003_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0266462306051221","article-title":"Genetic screening by DNA technology: a systematic review of health economic evidence","volume":"22","author":"Rogowski","year":"2006","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2013.05.003_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/GIM.0b013e3181837217","article-title":"Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis","volume":"10","author":"Grosse","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jval.2013.05.003_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1524-4733.2008.00476_1.x","article-title":"Economic evaluation for devices and drugs\u2014same or different?","volume":"12","author":"Drummond","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.05.003_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0266462310000309","article-title":"Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes","volume":"26","author":"Fr\u00f8nsdal","year":"2010","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2013.05.003_bib15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.05.003_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1524-4733.2009.00601.x","volume":"12","author":"Cox","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.05.003_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jval.2011.12.010","article-title":"Prospective observational studies to assess comparative effectiveness: the ISPOR Good Research Practices Task Force Report","volume":"15","author":"Berger","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.05.003_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1524-4733.2009.00602.x","volume":"12","author":"Johnson","year":"2009","journal-title":"Value Health"},{"issue":"23, Suppl. 1","key":"10.1016\/j.jval.2013.05.003_bib19","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jval.2013.05.003_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2796.1992.tb00565.x","article-title":"A prospective study of the incidence of deep-vein thrombosis within a defined urban population","volume":"232","author":"Nordstrom","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","article-title":"The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism","volume":"21","author":"Spencer","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France. EPIGETBO Study Group. Groupe d\u2019Etude de la Thrombose de Bretagne Occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib25","first-page":"65","article-title":"The changing pattern of venous thromboembolic disease","volume":"26","author":"Cohen","year":"1996","journal-title":"Haemostasis"},{"key":"10.1016\/j.jval.2013.05.003_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bmj.302.6778.709","article-title":"Incidence of venous thromboembolism verified by necropsy over 30 years","volume":"302","author":"Lindblad","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2013.05.003_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/014107688908200407","article-title":"Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?","volume":"82","author":"Sandler","year":"1989","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jval.2013.05.003_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1160\/TH09-01-0013","article-title":"The genetics of venous thromboembolism: a meta-analysis involving approximately 120,000 cases and 180,000 controls","volume":"102","author":"Gohil","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib29","first-page":"263","article-title":"Censimento delle strutture di Genetica Medica e dei test genetici in Italia-Anno 2004","volume":"6\/7","author":"Dallapiccola","year":"2006","journal-title":"Analysis"},{"key":"10.1016\/j.jval.2013.05.003_bib30","first-page":"207","article-title":"Censimento 2007 delle attivit\u00e0 delle strutture di Genetica Medica in Italia","volume":"4\/5","author":"Dallapiccola","year":"2009","journal-title":"Analysis"},{"key":"10.1016\/j.jval.2013.05.003_bib31","unstructured":"Consensus Conference Roma, 18\u201319 September 2008. Prevenzione delle complicanze trombotiche associate all\u2019uso di estro progestinici in et\u00e0 riproduttiva. Available from: http:\/\/www.snlg-iss.it\/cms\/files\/CC_EP_trombofilia.pdf. [Accessed May 30, 2012]."},{"key":"10.1016\/j.jval.2013.05.003_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00125817-200103000-00009","article-title":"American College of Medical Genetics consensus statement on factor V Leiden mutation testing","volume":"3","author":"Grody","year":"2001","journal-title":"Genet Med"},{"key":"10.1016\/j.jval.2013.05.003_bib33","first-page":"1","article-title":"Thrombophilia and venous thromboembolism: international consensus statement. Guidelines according to scientific evidence","volume":"24","author":"European Genetics Foundation","year":"2005","journal-title":"Int Angiol"},{"key":"10.1016\/j.jval.2013.05.003_bib34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(02)08740-8","article-title":"Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women","volume":"359","author":"Clark","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2013.05.003_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1160\/TH08-03-0149","article-title":"Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis","volume":"100","author":"Smith","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jval.2013.05.003_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jval.2013.05.003_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1160\/TH08-03-0149","article-title":"Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis","volume":"100","author":"Smith","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/qjmed\/94.7.365","article-title":"Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A","volume":"94","author":"Marchetti","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.jval.2013.05.003_bib41","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(07)61745-0","article-title":"Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study","volume":"370","author":"S\u00f8rensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2013.05.003_bib42","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0037-1615887","article-title":"Risk factors for venous thrombotic disease","volume":"82","author":"Rosendaal","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib43","series-title":"Medical Eligibility Criteria for Contraceptive Use","author":"Department of Reproductive Health, World Health Organization","year":"2010"},{"key":"10.1016\/j.jval.2013.05.003_bib44","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2013.05.003_bib45","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10110","article-title":"Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study","volume":"10","author":"Wu","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2013.05.003_bib47","first-page":"191","article-title":"Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.jval.2013.05.003_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2013.05.003_bib49","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2013.05.003_bib50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3324\/haematol.10967","article-title":"Risk of recurrence after a first venous thromboembolic event in young women","volume":"92","author":"Laczkovics","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jval.2013.05.003_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.annemergmed.2010.03.029","article-title":"Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms","volume":"56","author":"Duriseti","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jval.2013.05.003_bib52","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJM199406303302605","article-title":"A decision analysis of streptokinase plus heparin as compared to heparin alone for deep vein thrombosis","volume":"330","author":"O\u2019Meara","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2013.05.003_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-7525-8-49","article-title":"The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)","volume":"8","author":"Cadilhac","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2013.05.003_bib54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/027298902400448902","article-title":"Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)","volume":"22","author":"Clarke","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.05.003_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1477-7525-6-65","article-title":"Development and validation of a preference-based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses","volume":"6","author":"McKenna","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2013.05.003_bib56","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/j.1475-6773.2007.00702.x","article-title":"Public savings from the prevention of unintended pregnancy: a cost analysis of family planning services in California","volume":"42","author":"Amaral","year":"2007","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jval.2013.05.003_bib57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1650638","article-title":"Inherited thrombophilia: part 1","volume":"76","author":"Lane","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1055\/s-0038-1650673","article-title":"Inherited thrombophilia: part 2","volume":"76","author":"Lane","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jval.2013.05.003_bib59","unstructured":"ISTAT. Cause di morte Anno 2002. Annuario n. 18 \u2013 2007. Available from: http:\/\/www3.istat.it\/dati\/catalogo\/20070405_00\/ann_07_18_cause_di_morte_2002.pdf. [Accessed May 30, 2012]."},{"key":"10.1016\/j.jval.2013.05.003_bib60","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","article-title":"Variations in population health status: results from a United Kingdom national questionnaire survey","volume":"316","author":"Kind","year":"1998","journal-title":"BMJ"},{"issue":"4, Suppl.","key":"10.1016\/j.jval.2013.05.003_bib61","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/COC.0b013e3181b01b17","article-title":"The link between cancer and venous thromboembolism: a review","volume":"32","author":"Kessler","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jval.2013.05.003_bib62","series-title":"Prontuario Farmaceutico Nazionale","author":"AIFA","year":"2005"},{"key":"10.1016\/j.jval.2013.05.003_bib63","series-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Clinical Excellence","year":"2004"},{"key":"10.1016\/j.jval.2013.05.003_bib64","series-title":"Economic Evaluation in Health Care: Merging Theory with Practice","first-page":"172","article-title":"Holding uncertainty in economic evaluation and presenting the results","author":"Briggs","year":"2001"},{"key":"10.1016\/j.jval.2013.05.003_bib65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.39308.560069.BE","article-title":"NICE\u2019s cost effectiveness threshold","volume":"335","author":"Appleby","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2013.05.003_bib66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/ATVBAHA.109.184085","article-title":"Metabolic syndrome is associated with venous thromboembolism in the Korean population","volume":"29","author":"Jang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jval.2013.05.003_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0168-8510(96)00824-X","article-title":"Is regret theory an alternative basis for estimating the value of healthcare interventions?","volume":"37","author":"Smith","year":"2000","journal-title":"Health Policy"},{"key":"10.1016\/j.jval.2013.05.003_bib68","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0272989X08315249","article-title":"When is diagnostic testing inappropriate or irrational? Acceptable regret approach","volume":"28","author":"Hozo","year":"2008","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.05.003_bib69","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.jval.2013.05.003_bib70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00019053-200624040-00006","article-title":"Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment","volume":"24","author":"Philips","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2013.05.003_bib71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301513018196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301513018196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T07:46:46Z","timestamp":1563436006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301513018196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1098301513018196"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2013.05.003","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}